Lutetium Chloride

CHEMBL5316165 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
281.3 g/mol
LogP
Phase
4

This compound containing the rare earth metal lutetium is used as a precursor in nuclear medicine to label targeting molecules with radioactive lutetium-177 for targeted cancer therapy. The radioactive lutetium-177 version delivers localized radiation directly to tumor cells that express the targeted receptor.

分子量

281.3200 g/mol

TPSA

0.00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl[Lu](Cl)Cl

InChI

InChI=1S/3ClH.Lu/h3*1H;/q;;;+3/p-3

Molecular Formula

Cl3Lu

HBD / HBA

- / -

回転可能結合数

0

重原子数

4

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

This compound containing the rare earth metal lutetium is used as a precursor in nuclear medicine to label targeting molecules with radioactive lutetium-177 for targeted cancer therapy. The radioactive lutetium-177 version delivers localized radiation directly to tumor cells that express the targeted receptor.

Yes, Lutetium Chloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL5316165. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 24919. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.